E Galli1, M Fournet2, C Chabanne2, B Lelong2, A Leguerrier3, E Flecher3, P Mabo1, E Donal4. 1. Service de Cardiologie, 2 Rue Henri Le Guilloux, CHU Pontchaillou, Rennes 35000, France INSERM, UMR 1099, Rennes 35000, France LTSI, Université de Rennes, Rennes 35000, France. 2. Service de Cardiologie, 2 Rue Henri Le Guilloux, CHU Pontchaillou, Rennes 35000, France. 3. Service de Chirurgie Cardio-thoracique et Vasculaire, CHU Pontchaillou, Rennes 35000, France. 4. Service de Cardiologie, 2 Rue Henri Le Guilloux, CHU Pontchaillou, Rennes 35000, France INSERM, UMR 1099, Rennes 35000, France LTSI, Université de Rennes, Rennes 35000, France erwan.donal@chu-rennes.fr.
Abstract
AIMS: The aim of this article is to assess the left atrial (LA) reservoir function in patients with severe aortic stenosis (AS) and to evaluate its impact on the recurrence of major adverse cardiac events (MACEs). METHODS AND RESULTS: About 128 patients (mean age 79 ± 9 years) with severe AS were included in the study. Global peak LA strain (PLAS) measured by two-dimensional speckle-tracking echocardiography (STE) during left ventricular (LV) systole represented the LA reservoir function. Overall death, hospitalization for cardiac cause, and worsening heart failure were defined as MACEs. With respect to the values observed in a control group of 20 healthy patients, PLAS resulted significantly reduced in AS. According to the multivariate linear regression analysis, LV global longitudinal strain, mitral E/e' ratio, and systolic pulmonary arterial pressure (sPAP) were the best correlates to PLAS. During follow-up, the predefined MACEs occurred in 39 patients. According to the multivariate Cox regression analysis, a PLAS <21% was a significant predictor of MACEs [hazard ratio (HR) 2.88, P = 0.04], as was coronary artery disease (HR 2.68, P = 0.004) and the New York Heart Association functional class (HR 2.08, P = 0.03). CONCLUSION: In patients with severe AS, a global PLAS <21% is an independent predictor of prognosis. Given the combined influence of LV diastolic and systolic function and of LA performance on sPAP, the decline of PLAS might be considered a marker of global myocardial impairment in AS. Further studies are needed to confirm the critical role of LA relaxation in prognosis and to validate its relevance in routine clinical practice. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The aim of this article is to assess the left atrial (LA) reservoir function in patients with severe aortic stenosis (AS) and to evaluate its impact on the recurrence of major adverse cardiac events (MACEs). METHODS AND RESULTS: About 128 patients (mean age 79 ± 9 years) with severe AS were included in the study. Global peak LA strain (PLAS) measured by two-dimensional speckle-tracking echocardiography (STE) during left ventricular (LV) systole represented the LA reservoir function. Overall death, hospitalization for cardiac cause, and worsening heart failure were defined as MACEs. With respect to the values observed in a control group of 20 healthy patients, PLAS resulted significantly reduced in AS. According to the multivariate linear regression analysis, LV global longitudinal strain, mitral E/e' ratio, and systolic pulmonary arterial pressure (sPAP) were the best correlates to PLAS. During follow-up, the predefined MACEs occurred in 39 patients. According to the multivariate Cox regression analysis, a PLAS <21% was a significant predictor of MACEs [hazard ratio (HR) 2.88, P = 0.04], as was coronary artery disease (HR 2.68, P = 0.004) and the New York Heart Association functional class (HR 2.08, P = 0.03). CONCLUSION: In patients with severe AS, a global PLAS <21% is an independent predictor of prognosis. Given the combined influence of LV diastolic and systolic function and of LA performance on sPAP, the decline of PLAS might be considered a marker of global myocardial impairment in AS. Further studies are needed to confirm the critical role of LA relaxation in prognosis and to validate its relevance in routine clinical practice. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Andrea Sonaglioni; Gian Luigi Nicolosi; Elisabetta Rigamonti; Michele Lombardo Journal: Int J Cardiovasc Imaging Date: 2021-02-05 Impact factor: 2.357
Authors: Andreea Calin; Anca D Mateescu; Monica Rosca; Carmen C Beladan; Roxana Enache; Simona Botezatu; Iulian Cosei; Cosmin Calin; Marian Simion; Carmen Ginghina; Andreea C Popescu; Bogdan A Popescu Journal: Int J Cardiovasc Imaging Date: 2017-07-15 Impact factor: 2.357
Authors: Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi Journal: Front Cardiovasc Med Date: 2022-01-13
Authors: P Meimoun; V Stracchi; J Boulanger; S Martis; T Botoro; H Zemir; J Clerc Journal: Int J Cardiovasc Imaging Date: 2019-10-31 Impact factor: 2.357
Authors: Maria Concetta Pastore; Giuseppe De Carli; Giulia Elena Mandoli; Flavio D'Ascenzi; Marta Focardi; Francesco Contorni; Sergio Mondillo; Matteo Cameli Journal: Heart Fail Rev Date: 2021-11 Impact factor: 4.214
Authors: Jolanda Sabatino; Salvatore De Rosa; Isabella Leo; Antonio Strangio; Sabrina La Bella; Sabato Sorrentino; Annalisa Mongiardo; Carmen Spaccarotella; Alberto Polimeni; Ciro Indolfi Journal: Open Heart Date: 2021-07